NEW YORK (TheStreet) -- HealthSouth (HLS) shares are down 1.5% to $39.94 in after-hours trading on Monday after the company released its third quarter earnings results after the closing bell today.
The country's largest owner and operator of inpatient rehabilitation hospitals reported a 5.8% increase in consolidated net operating revenues to $596.9 million, ahead of analysts expectations of $595.2 million.
Must Read: Warren Buffett's 25 Favorite Stocks
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
Earnings for the period were 53 cents per diluted share, 4 cents better than the consensus analysts expectations.
However, the company's shares are declining after it narrowed its full year earnings guidance to between $2.24 and $2.27 per diluted share from its previous expectations of $2.25 to $2.31 per share. TheStreet Ratings team rates HEALTHSOUTH CORP as a Buy with a ratings score of B. TheStreet Ratings Team has this to say about their recommendation: "We rate HEALTHSOUTH CORP (HLS) a BUY. This is driven by several positive factors, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations, increase in stock price during the past year, expanding profit margins and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income." Highlights from the analysis by TheStreet Ratings Team goes as follows: You can view the full analysis from the report here: HLS Ratings Report 
HLS data by YCharts
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.
No comments:
Post a Comment